期刊簡介預計審稿時間： 約1.5月

Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.

Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.

Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.

Endocrine 是當今快速發(fā)展的實驗和臨床研究領域的主要期刊，發(fā)表致力于內分泌和代謝各個領域的基礎（包括分子、細胞和生理研究）、轉化和臨床研究的原創(chuàng)文章。文章的接受將基于同行評審、優(yōu)先級和編輯決定。期刊將發(fā)表受邀評論、小型評論和相關病理生理和臨床主題的觀點，以及期刊文章的社論。編輯團隊將評估未經(jīng)請求的社論?？梢蕴峤豢茖W會議的成果以及指南和立場聲明。期刊還考慮內分泌遺傳學和表觀遺傳學領域的專題文章，以及致力于內分泌學新方法和技術的文章。

Endocrine 涵蓋有爭議的臨床內分泌問題。還接受內分泌和代謝主題的薈萃分析。除非有特別的興趣，否則不會發(fā)表單個臨床病例和/或小患者研究的描述。但是，可以考慮單個患者的新型成像研究和內分泌副作用報告?？梢蕴峤慌c最近發(fā)表的文章相關或不相關的研究信和致編輯的信。

內分泌涵蓋內分泌學的主要主題，例如神經(jīng)內分泌學、垂體和下丘腦肽、甲狀腺生理和臨床方面、骨骼和礦物質代謝和骨質疏松癥、肥胖、脂質和能量代謝和食物攝入控制、胰島素、1 型和 2 型糖尿病、男性和女性生殖激素、腎上腺疾病兒科和老年內分泌學、內分泌性高血壓和內分泌腫瘤學。

《Endocrine》(內分泌)編輯部通訊方式為ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United States, NY, 10004。如果您需要協(xié)助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發(fā)表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。